SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-026078
Filing Date
2023-07-31
Accepted
2023-07-31 16:20:27
Documents
13
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 208999
2 ex31-1.htm EX-31.1 18536
  Complete submission text file 0001493152-23-026078.txt   466906

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE eltp-20230331.xsd EX-101.SCH 3024
4 XBRL LABEL FILE eltp-20230331_lab.xml EX-101.LAB 36884
5 XBRL PRESENTATION FILE eltp-20230331_pre.xml EX-101.PRE 24152
7 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 6027
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-15697 | Film No.: 231127649
SIC: 2834 Pharmaceutical Preparations